Regular follow-up is also needed so it may work well and support your fight against obesity and related risks
The short answer is yes, with appropriate monitoring
Semaglutide (Ozempic, Wegovy, Rybelsus) Semaglutide is the most widely prescribed GLP-1 receptor agonist, available as both injectable (Ozempic for diabetes, Wegovy for weight management) and oral (Rybelsus) formulations
For a closer look at how this can show up in practice, our semaglutide chills explainer breaks down why cold sensitivity can happen during treatment
Metformin has also been associated with undesired side-effects, as gastrointestinal distress, and has modest effects on body weight in women with PCOS and obesity 25
It is outlined in Section 503A and Section 503B of the U.S